View : 772 Download: 0
Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw
- Title
- Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw
- Authors
- Kim J.-W.; Cha I.-H.; Kim S.-J.; Kim M.-R.
- Ewha Authors
- 김명래; 김선종; 김진우
- SCOPUS Author ID
- 김명래; 김선종; 김진우
- Issue Date
- 2016
- Journal Title
- Clinical Implant Dentistry and Related Research
- ISSN
- 1523-0899
- Citation
- Clinical Implant Dentistry and Related Research vol. 18, no. 2, pp. 281 - 291
- Keywords
- Biomarker; Bisphosphonate; Osteonecrosis of the jaw; Receptor activator of nuclear factor-κβ ligand; Tartrate-resistant acid phosphatase
- Publisher
- Blackwell Publishing Ltd
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Purpose: The aim of this study was to investigate a possible biomarker for bisphosphonate-related osteonecrosis of the jaw (BRONJ) in an animal model. Materials and Methods: Forty-eight Sprague-Dawley rats were randomly divided into the bisphosphonate group (n=36), who were injected once a week with zoledronic acid, and the control group (n=12), who were injected once a week with saline. After 6 weeks, surgical intervention was performed, and injections were continued up to 8 weeks. Rats in the bisphosphonate group were then further classified to the ONJ group, and the non-ONJ group, and biomarkers, including CTx, Glu-OC, TRACP 5b, RANKL, and OPG, were assessed at baseline (T0), at surgical intervention (T1), and at sacrifice (T2). Histomorphometric analysis for quantification of osteoclasts was performed. Results: Repeated measures analysis of variance revealed that TRACP 5b levels and the RANKL/OPG ratio were significantly decreased over time in the ONJ group compared with the non-ONJ group (p<.05). At T2, the area under the curve was 0.807 for TRACP 5b (sensitivity: 88.9%, specificity 66.7% at cutoff) and 0.765 for the RANKL/OPG ratio (sensitivity: 77.8%, specificity 62.9% at cutoff). TRACP 5b showed a lower least significant change (29.6%) with lower intra-assay coefficient of variability (CV; 6.32%) and interassay CV (11.20%) compared with those of the RANKL/OPG ratio (39.27%) and showed a higher signal-to-noise ratio (2.76) than that of the RANKL/OPG ratio (1.62). N.Oc/T.Ar and N.Oc/B.Ar demonstrated significantly decreased number of osteoclasts in ONJ group versus non-ONJ group. Conclusions: These results show that serum TRACP 5b and the RANKL/OPG ratio were possible biomarkers for BRONJ. These data may provide useful additional information for future ONJ research. Further studies are needed to validate these results in humans with ONJ. © 2016 Wiley Periodicals, Inc.
- DOI
- 10.1111/cid.12297
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML